 |
PDBsum entry 1ieh
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
1ieh
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
41:8570-8579
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of a llama single-domain antibody with hydrophobic residues typical of the VH/VL interface.
|
|
W.Vranken,
D.Tolkatchev,
P.Xu,
J.Tanha,
Z.Chen,
S.Narang,
F.Ni.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The three-dimensional structure of a llama single-domain antibody BrucD4-4 was
established by use of solution NMR spectroscopy. BrucD4-4 has Val, Gly, Leu, and
Trp residues at positions 37, 44, 45, and 47, which are considered to be a
hallmark to distinguish llama VH from V(H)H fragments at the germline level. In
contrast to the murine and human VHs, BrucD4-4 has sufficient solubility, is
monomeric in solution, and displays high-quality NMR spectra characteristic of
well-structured proteins. Amide proton/deuterium exchange and the (15)N
relaxation data showed that BrucD4-4 has a classic protein structure with a
well-packed core and comparatively mobile surface loops. The three-dimensional
architecture of BrucD4-4 is analogous to that of VHs from murine and human F(v)s
and camelid V(H)Hs with two pleated beta-sheets formed by four and five
beta-strands. A canonical and undistorted beta-barrel exposes a number of
hydrophobic residues into the solvent on the surface of the three-dimensional
structure. The eight-residue H3 loop folds over the side chain of Val37
similarly to that in llama V(H)Hs; however, this interaction may be transient
due to the H3 conformational flexibility. Overall, the surface characteristics
of BrucD4-4 with respect to hydrophobicity appear to lie between the human VH
domain from Fv Pot and the llama V(H)H fragment HC-V, which may explain its
enhanced solubility allowing NMR structural analysis.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
F.Rahbarizadeh,
D.Ahmadvand,
and
Z.Sharifzadeh
(2011).
Nanobody; an old concept and new vehicle for immunotargeting.
|
| |
Immunol Invest,
40,
299-338.
|
 |
|
|
|
|
 |
P.A.Barthelemy,
H.Raab,
B.A.Appleton,
C.J.Bond,
P.Wu,
C.Wiesmann,
and
S.S.Sidhu
(2008).
Comprehensive Analysis of the Factors Contributing to the Stability and Solubility of Autonomous Human VH Domains.
|
| |
J Biol Chem,
283,
3639-3654.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Q.F.Miao,
X.Y.Liu,
B.Y.Shang,
Z.G.Ouyang,
and
Y.S.Zhen
(2007).
An enediyne-energized single-domain antibody-containing fusion protein shows potent antitumor activity.
|
| |
Anticancer Drugs,
18,
127-137.
|
 |
|
|
|
|
 |
H.Revets,
P.De Baetselier,
and
S.Muyldermans
(2005).
Nanobodies as novel agents for cancer therapy.
|
| |
Expert Opin Biol Ther,
5,
111-124.
|
 |
|
|
|
|
 |
S.Megy,
G.Bertho,
J.Gharbi-Benarous,
N.Evrard-Todeschi,
G.Coadou,
E.Ségéral,
C.Iehle,
E.Quéméneur,
R.Benarous,
and
J.P.Girault
(2005).
STD and TRNOESY NMR studies on the conformation of the oncogenic protein beta-catenin containing the phosphorylated motif DpSGXXpS bound to the beta-TrCP protein.
|
| |
J Biol Chem,
280,
29107-29116.
|
 |
|
|
|
|
 |
M.Huang,
B.Zhang,
J.Wang,
F.Mei,
and
L.Hou
(2004).
Development of single-domain recombinant antibodies to reverse transcriptase domain of human hTERT.
|
| |
Hybrid Hybridomics,
23,
244-249.
|
 |
|
|
|
|
 |
R.L.Stanfield,
H.Dooley,
M.F.Flajnik,
and
I.A.Wilson
(2004).
Crystal structure of a shark single-domain antibody V region in complex with lysozyme.
|
| |
Science,
305,
1770-1773.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.J.Holt,
C.Herring,
L.S.Jespers,
B.P.Woolven,
and
I.M.Tomlinson
(2003).
Domain antibodies: proteins for therapy.
|
| |
Trends Biotechnol,
21,
484-490.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |